Prevalence of SARS-CoV-2 Antibodies From National Serosurveillance of Kenyan Blood Donors

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 2, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.15265?guestAccessKey=7c0d3707-b36f-4b04-9127-8642571ca6ce&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221

 

What The Study Did: This study examines how common SARS-CoV-2 antibodies were among blood donors ages 16 to 64 in Kenya from January to March.

Authors: Sophie Uyoga, Ph.D., of the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya, is the corresponding author.

 

(doi:10.1001/jama.2021.15265)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.